Cheaper GLP-1 pills are here, but most patients still choose injections—even with a higher price tag. Is it habit, trust, or something more? Dive into the surprising reasons why the needle wins in a booming obesity drug market racing toward $100 billion by 2030. #GLP1 #HealthChoices #ObesityDrugs
Watch this Short on CAxTube @retapensuk
Read the source article or discussion
Community education only; personal experiences and source claims should be checked against reliable health guidance. This is not medical advice, diagnosis or prescribing guidance.